|
La giornata non sarà da perdere, perché sui palchi dello Sziget arriveranno Liam Gallagher, Stormzy (aka Big Mike, principale voce del grime), Yves Tumor e i suoi soundscape imprevedibili, Teezo ...
Rolling Stone
-
5-6-2024
|
|
|
|
ADCs are an expanding class of therapies designed to target and kill tumor cells while sparing healthy cells. These very targeted therapies are available to patients with specific indications, ...
01Net
-
2-6-2024
|
|
|
|
... wildtype and mutants with favorable pharmacological properties, as well as promising anti - tumor activities in ER - positive animal tumor models. The purpose of the Phase 1 multi - center, open - ...
01Net
-
1-6-2024
|
|
|
|
By partnering with Genialis, we will lever the data from PanCAN's Know Your Tumor precision medicine service to further validate Genialis krasID biomarker performance in pancreatic cancer,' said Anna ...
01Net
-
31-5-2024
|
|
|
|
... 'Our AI engines integrated rich multimodal patient data from multiple cancer indications, allowing us to discover that EP2/EP4 biology significantly perturbs T cell connectivity within the tumor ...
01Net
-
23-5-2024
|
|
|
|
... Title: Retrospective Analysis of mRNA Expression Based Signatures of Thyroid Tumor Invasion and Metastases Presenter: Sara Ahmadi, M. D., Brigham and Women's Hospital Format: Poster Presentation (...
01Net
-
23-5-2024
|
|
|
|
We are hopeful that DF9001 in combination with KEYTRUDA will drive potent anti - tumor activity in a broad range of indications and are excited to further accelerate progress in the clinic to benefit ...
Adnkronos
-
21-5-2024
|
|
|
|
I vincitori delle tre categorie in cui era suddiviso il premio sono stati: NOVOCURE, per Tumor Treating Fields: innovazione terapeutica per il trattamento dei tumori solidi (categoria Diagnostica - ...
QuotidianoSanità.it
-
20-5-2024
|
|
|
|
...responsabile del progetto di ricerca Istituto di analisi dei sistemi ed informatica "Antonio Ruberti" (IASI) PRIN 2017 - PRIN2017S55RXB - Antonella Farsetti - New Biomarkers for Pituitary Tumor (DIT. ...
CNR
-
18-5-2024
|
|
|
|
"Sarà sempre più importante che i Molecular Tumor Board, formati da farmacologi, oncologi, anatomopatologi e biologi lavorino a stretto contatto per interpretare l'esito delle analisi genomiche e ...
Gente d'Italia
-
18-5-2024
|
|
|
|
|
|
